US Patent Issued to NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING on Sept. 22 for "Specific host factor of hepatitis B virus infection, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,164, issued on Sept. 22, was assigned to NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (Beijing).

"Specific host factor of hepatitis B virus infection, and use thereof" was invented by Cong Li (Beijing), Yixue Wang (Beijing) and Wenhui Li (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a host factor specific for hepatitis B virus (HBV) infection. The specific host factor CREBH can remarkably enhance HBV infection. The specific host factor can, on the one hand, enhance entry of HBV, and on the other hand, enhance transcription of HBV to some extent. In the CREBH regulatory pathway there is a specific host factor SCARF2. Duri...